DrugPatentWatch Database Preview
Apomorphine hydrochloride - Generic Drug Details
» See Plans and Pricing
What are the generic drug sources for apomorphine hydrochloride and what is the scope of patent protection?
Apomorphine hydrochloride
is the generic ingredient in two branded drugs marketed by Sunovion Pharms Inc and Mdd Us, and is included in two NDAs. There are fourteen patents protecting this compound. Additional information is available in the individual branded drug profile pages.Apomorphine hydrochloride has two hundred and thirty-six patent family members in twenty-four countries.
There are six drug master file entries for apomorphine hydrochloride. Two suppliers are listed for this compound.
Summary for apomorphine hydrochloride
| International Patents: | 236 |
| US Patents: | 14 |
| Tradenames: | 2 |
| Applicants: | 2 |
| NDAs: | 2 |
| Drug Master File Entries: | 6 |
| Suppliers / Packagers: | 2 |
| Bulk Api Vendors: | 48 |
| Clinical Trials: | 40 |
| Patent Applications: | 4,351 |
| Formulation / Manufacturing: | see details |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for apomorphine hydrochloride |
| DailyMed Link: | apomorphine hydrochloride at DailyMed |
Recent Clinical Trials for apomorphine hydrochloride
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University Hospital, Lille | Phase 1/Phase 2 |
| Western University, Canada | N/A |
| Alexza Pharmaceuticals, Inc. | Phase 1 |
Pharmacology for apomorphine hydrochloride
| Drug Class | Dopaminergic Agonist |
| Mechanism of Action | Dopamine Agonists |
Medical Subject Heading (MeSH) Categories for apomorphine hydrochloride
US Patents and Regulatory Information for apomorphine hydrochloride
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sunovion Pharms Inc | KYNMOBI | apomorphine hydrochloride | FILM;SUBLINGUAL | 210875-002 | May 21, 2020 | RX | Yes | No | Start Trial | Start Trial | Y | Start Trial | |||
| Sunovion Pharms Inc | KYNMOBI | apomorphine hydrochloride | FILM;SUBLINGUAL | 210875-003 | May 21, 2020 | RX | Yes | No | Start Trial | Start Trial | Y | Start Trial | |||
| Sunovion Pharms Inc | KYNMOBI | apomorphine hydrochloride | FILM;SUBLINGUAL | 210875-005 | May 21, 2020 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| Sunovion Pharms Inc | KYNMOBI | apomorphine hydrochloride | FILM;SUBLINGUAL | 210875-004 | May 21, 2020 | RX | Yes | No | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for apomorphine hydrochloride
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| China | 1764443 | Start Trial |
| European Patent Office | 2079457 | Start Trial |
| Japan | 2011140507 | Start Trial |
| Argentina | 077803 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2020 - 2021
NCE-1 Patent Challenge Dates 2020 - 2021
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2020, www.DrugPatentWatch.com.
Follow DrugPatentWatch:
